Dr. Arpeet Shah discusses refining prostate cancer risk stratification.

Dr. Arpeet Shah Urology Times

Dr. Arpeet Shah recently participated in a two-part discussion October 14, 2025 with Dr. Jason Hafron, CMO of Michigan Institute of Urology and cochair of the Solaris clinical board.  This was a deep dive into how structure-based biomarkers like IsoPSA are refining prostate cancer risk stratification. In this discussion hosted by Urology Times, Dr. Arpeet…

Read More

Dr. Aaron Berger On Urology Times Panel

Dr. Aaron Berger Interviews with Urology Times

A leading Urological publication, Urology Times, recently invited Dr. Aaron Berger, Chief Medical Officer and Director of Clinical Research at Associated Urological Specialists, to be interviewed with a panel of distinguished peers. The eleven episode series that came out of those interviews have become an insightful look into prostate cancer management.

Read More